Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a U.K. dual centre experience.
Suzy MortonR DanbyH OsmanA PeniketV RochaC CraddockM MurphyS ChagantiPublished in: Transfusion medicine (Oxford, England) (2015)
Our findings confirm the safety of leukocyte reduction as a strategy in preventing TT-CMV in high-risk allogeneic SCT recipients.